title: Supportive care in hemato-oncology: a review in light of the latest guidelines.
abstract: Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines.
authors.affiliation: Eskişehir Osmangazi University, School of Medicine, Department of Hematology, Eskişehir, Turkey.
authors.forename: Eren
authors.initials: E
authors.lastname: Gündüz
authors.affiliation: Anadolu Health Center, Bone Marrow Transplantation Center, Kocaeli, Turkey.
authors.forename: Zafer
authors.initials: Z
authors.lastname: Gülbaş
keywords: Anemia; Hematology; Nausea/vomiting; Neutropenia; Supportive care
references.citation: Br J Hosp Med. 1997 Nov 5-18;58(9):442-5
references.pmid: 9619205
references.citation: Am J Health Syst Pharm. 2007 Feb 1;64(3 Suppl 2):S5-13; quiz S28-30
references.pmid: 17244886
references.citation: J Clin Psychiatry. 2001;62 Suppl 7:22-31
references.pmid: 11346192
references.citation: J Clin Oncol. 2005 Sep 1;23(25):5960-72
references.pmid: 16087945
references.citation: Support Care Cancer. 2007 May;15(5):497-503
references.pmid: 17103197
references.citation: Support Care Cancer. 2010 Feb;19(2):251-9
references.pmid: 20101414
references.citation: J Natl Compr Canc Netw. 2010 Feb;8(2):162-200
references.pmid: 20141676
references.citation: Gastroenterol Nurs. 2005 Nov-Dec;28(6):469-80
references.pmid: 16418583
references.citation: J Clin Oncol. 2006 Jul 1;24(19):3187-205
references.pmid: 16682719
references.citation: Eur J Cancer. 2000 Apr;36 Suppl 1:S11-4
references.pmid: 10785604
references.citation: Am J Med. 2004 Apr 5;116 Suppl 7A:11S-26S
references.pmid: 15050883
references.citation: J Clin Oncol. 1991 Feb;9(2):286-94
references.pmid: 1988575
references.citation: Neuropsychopharmacology. 1996 Feb;14(2):87-96
references.pmid: 8822531
references.citation: Ann Oncol. 2003 Jan;14(1):29-35
references.pmid: 12488289
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1040-50
references.pmid: 18227526
references.citation: N Engl J Med. 1995 Jan 5;332(1):1-5
references.pmid: 7990859
references.citation: Cochrane Database Syst Rev. 2004;(1):CD003189
references.pmid: 14974009
references.citation: J Support Oncol. 2007 May;5(5 Suppl 3):1-9
references.pmid: 17566383
references.citation: J Thromb Haemost. 2007 Mar;5(3):632-4
references.pmid: 17319909
references.citation: J Natl Cancer Inst. 2001 Jan 3;93(1):31-8
references.pmid: 11136839
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4472-8
references.pmid: 16983116
references.citation: J Clin Oncol. 2000 Jul;18(13):2522-8
references.pmid: 10893282
references.citation: Oncology (Williston Park). 2010 Mar;24(3):260-8
references.pmid: 20394138
references.citation: Cancer. 2001 Jun 15;91(12):2214-21
references.pmid: 11413508
references.citation: Science. 2005 Oct 14;310(5746):329-32
references.pmid: 16224028
references.citation: J Natl Compr Canc Netw. 2008 Feb;6(2):109-18
references.pmid: 18319047
references.citation: J Clin Oncol. 2005 Jun 20;23(18):4198-214
references.pmid: 15961767
references.citation: Oncologist. 2009;14 Suppl 1:43-56
references.pmid: 19762516
references.citation: Biochem Pharmacol. 2009 May 15;77(10):1572-9
references.pmid: 19174153
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2932-47
references.pmid: 16717289
references.citation: J Clin Oncol. 2005 Feb 20;23(6):1178-84
references.pmid: 15718314
references.citation: Lancet. 2003 Oct 18;362(9392):1255-60
references.pmid: 14575968
references.citation: Bone Marrow Transplant. 2007 Aug;40(3):185-92
references.pmid: 17563736
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3242-7
references.pmid: 18519748
references.citation: Expert Rev Anticancer Ther. 2004 Oct;4(5):715-24
references.pmid: 15485308
references.citation: Arch Intern Med. 2000 Mar 27;160(6):809-15
references.pmid: 10737280
references.citation: Leuk Res. 2010 Dec;34(12):1576-88
references.pmid: 20149927
references.citation: J Clin Oncol. 2001 Jun 1;19(11):2865-74
references.pmid: 11387359
references.citation: Psychosomatics. 1999 Sep-Oct;40(5):438-43
references.pmid: 10479950
references.citation: J Natl Compr Canc Netw. 2007 Feb;5(2):188-202
references.pmid: 17335688
references.citation: J Clin Oncol. 2005 Oct 20;23(30):7614-20
references.pmid: 16186594
references.citation: Crit Rev Oncol Hematol. 2009 Nov;72(2):144-54
references.pmid: 19237297
references.citation: J Natl Cancer Inst. 1999 Oct 6;91(19):1616-34
references.pmid: 10511589
references.citation: Eur J Pharmacol. 2001 Nov 2;430(2-3):341-9
references.pmid: 11711053
references.citation: Drugs. 2000 Sep;60(3):533-46
references.pmid: 11030465
references.citation: J Clin Oncol. 2007 Mar 20;25(9):1027-32
references.pmid: 17312332
references.citation: Gynecol Oncol. 2008 Feb;108(2):317-25
references.pmid: 18037478
references.citation: Ann Oncol. 1993 Sep;4(8):651-6
references.pmid: 7694634
references.citation: Support Care Cancer. 2005 Feb;13(2):80-4
references.pmid: 15599601
references.citation: Radiother Oncol. 1998 Jul;48(1):23-7
references.pmid: 9756168
references.citation: J Clin Oncol. 1990 Jun;8(6):963-77
references.pmid: 2348230
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1022-4
references.pmid: 18227523
references.citation: J Support Oncol. 2006 Feb;4(2 Suppl 1):3-8
references.pmid: 16499138
references.citation: Br J Haematol. 2003 Aug;122(3):394-403
references.pmid: 12877666
references.citation: Support Care Cancer. 2004 Aug;12(8):550-4
references.pmid: 15232725
references.citation: J Natl Cancer Inst. 1998 Aug 19;90(16):1205-11
references.pmid: 9719081
references.citation: J Support Oncol. 2006 Oct;4(9):472-8
references.pmid: 17080736
references.citation: J Natl Cancer Inst. 2006 May 17;98(10):708-14
references.pmid: 16705125
references.citation: Expert Opin Pharmacother. 2009 Mar;10(4):629-44
references.pmid: 19284365
references.citation: J Support Oncol. 2004 Jul-Aug;2(4):305-14; discussion 314-6
references.pmid: 15357514
references.citation: Lancet. 2003 May 17;361(9370):1703-5
references.pmid: 12767738
references.citation: Br J Haematol. 2003 Oct;123(1):22-33
references.pmid: 14510939
references.citation: Support Care Cancer. 2002 Apr;10(3):181-8
references.pmid: 11904782
references.citation: J Natl Cancer Inst. 2002 Aug 21;94(16):1211-20
references.pmid: 12189224
references.citation: Eur J Cancer. 2006 Oct;42(15):2433-53
references.pmid: 16750358
references.citation: J Support Oncol. 2003 Jul-Aug;1(2):89-103
references.pmid: 15352652
references.citation: N Engl J Med. 2007 Jun 14;356(24):2448-51
references.pmid: 17568025